Shuling Ma

Shandong Provincial Key Laboratory Of Precision Oncology
Jinan, 250117, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Antibiotics and probiotics differentially shape immunotherapy outcomes in non-small cell lung cancer.

Antibiotics and probiotics differentially shape immunotherapy outcomes in non-small cell lung cancer.

Journal: Cancer biology & medicine

Published: May 30, 2026

The use of antibiotic, probiotic, and FMT in modulating Immunotherapy Efficacy and Survival: a systematic review and meta-analysis of clinical outcomes.

The use of antibiotic, probiotic, and FMT in modulating Immunotherapy Efficacy and Survival: a systematic review and meta-analysis of clinical outcomes.

Journal: The oncologist

Published: April 05, 2026

Vertebral body dosimetry associated with hematologic toxicities and survival in esophageal squamous-cell carcinoma treated with chemoradiotherapy plus immunotherapy.

Vertebral body dosimetry associated with hematologic toxicities and survival in esophageal squamous-cell carcinoma treated with chemoradiotherapy plus immunotherapy.

Journal: Frontiers in immunology

Published: March 17, 2026

Mechanistic study of α-glucosidase and α-amylase inhibition by taxifolin.

Mechanistic study of α-glucosidase and α-amylase inhibition by taxifolin.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: February 26, 2026

Mechanistic insights into Helicobacter pylori urease inhibition by poplar propolis ethanol extract.

Mechanistic insights into Helicobacter pylori urease inhibition by poplar propolis ethanol extract.

Journal: Journal of ethnopharmacology

Published: February 04, 2026

Enzyme kinetics and multi-spectroscopic analyses reveal the inhibitory effect and interaction mechanism of taxifolin on urease.

Enzyme kinetics and multi-spectroscopic analyses reveal the inhibitory effect and interaction mechanism of taxifolin on urease.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: September 24, 2025

Circulating Tumor DNA is Associated With Pathologic Response and Survival Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy: A Systematic Review and Meta-Analysis.

Circulating Tumor DNA is Associated With Pathologic Response and Survival Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy: A Systematic Review and Meta-Analysis.

Journal: Archivos de bronconeumologia

Published: September 15, 2025

Intratumoral microbiota and metabolites: dual roles in cancer progression and therapeutic opportunities.

Intratumoral microbiota and metabolites: dual roles in cancer progression and therapeutic opportunities.

Journal: Cell communication and signaling : CCS

Published: July 24, 2025

Targeting gut microbiota and metabolites in cancer radiotherapy.

Targeting gut microbiota and metabolites in cancer radiotherapy.

Journal: Clinical and translational medicine

Published: April 01, 2025

Gut Escherichia coli promotes lung cancer by increasing circulating STAMBP production.

Gut Escherichia coli promotes lung cancer by increasing circulating STAMBP production.

Journal: Discover oncology

Published: November 25, 2024

Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid.

Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid.

Journal: Cell reports

Published: June 28, 2024

Showing 1-11 of 11

Last Updated: 09/26/2026